Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Cytarabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 113 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Myelodysplastic Syndromes 25 Leukemia 24 Burkitt Lymphoma 21 Leukemia, Biphenotypic, Acute 17 Recurrence 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Mantle-Cell 11 Leukemia, Myelomonocytic, Chronic 10 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Lymphoma 6 Sarcoma, Myeloid 5 Neoplasm, Residual 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Monocytic, Acute 5 Hodgkin Disease 5 Leukemia, Myelomonocytic, Acute 4 Hematologic Neoplasms 4 Lymphoma, Follicular 3 Down Syndrome 3 Blast Crisis 3 Multiple Myeloma 2 Lymphoma, T-Cell 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myeloid 2

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡